KZA — Kazia Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMicro Cap
- AU$18.24m
- AU$14.80m
- AU$0.02m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -6.71 | -8.81 | 1.02 | 0.025 | 0.023 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -6.71 | -8.81 | -9.11 | -22.8 | -15.2 |
Capital Expenditures | 0 | 0 | — | — | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 2.36 | 0 | 0 | -2.36 | 0 |
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 2.36 | 0 | 0 | -2.36 | 0 |
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 3.82 | 12.1 | 28.1 | 3.73 | 13 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.522 | 3.33 | 18.8 | -20.2 | -2.12 |